Ashburton gold project delivers outstanding drill results
Slightly above 715827949 percent of Kezar Life's retail investors are aggressively looking to sell. The analysis of the overall investor sentiment regarding Kezar Life Sciences suggests that quite a large number of traders are panicking. Kezar Life's investing sentiment overview a quick insight into current market opportunities from investing in Kezar Life Sciences. Many technical investors use Kezar Life Sciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Kezar |
De Grey Mining has extended the option period to aquire Kalamazoo Resources Ashburton gold project by six months.
Read at australianmining.com.au
 |
Kezar Life Fundamental Analysis
We analyze Kezar Life's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kezar Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kezar Life based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Kezar Life is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Kezar Life Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kezar Life stock to make a market-neutral strategy. Peer analysis of Kezar Life could also be used in its relative valuation, which is a method of valuing Kezar Life by comparing valuation metrics with similar companies.
Peers
Kezar Life Related Equities
| NKTX | Nkarta | 2.18 | ||||
| KROS | Keros Therapeutics | 2.17 | ||||
| SRZN | Surrozen | 1.44 | ||||
| LRMR | Larimar Therapeutics | 0.98 | ||||
| RVMD | Revolution Medicines | 0.18 | ||||
| KYMR | Kymera Therapeutics | 0.09 | ||||
| IKNA | Ikena Oncology | 0.60 | ||||
| NRIX | Nurix Therapeutics | 1.41 | ||||
| STOK | Stoke Therapeutics | 2.11 | ||||
| MLYS | Mineralys Therapeutics, | 2.22 | ||||
| IPSC | Century Therapeutics | 2.40 | ||||
| GLUE | Monte Rosa | 2.95 | ||||
| HOWL | Werewolf Therapeutics | 3.51 | ||||
| CGEM | Cullinan Oncology | 3.69 | ||||
| STTK | Shattuck Labs | 5.00 | ||||
| BOLT | Bolt Biotherapeutics | 5.36 | ||||
| FHTX | Foghorn Therapeutics | 8.30 | ||||
| DSGN | Design Therapeutics | 8.79 | ||||
| LYEL | Lyell Immunopharma | 11.84 |
Additional Tools for Kezar Stock Analysis
When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.